May 10, 2022
Orion to Exit Rare Disease Drug Development
Read More
May 5, 2022
BridgeBio, Looking to Conserve Cash, Sheds Programs
Read More
April 28, 2022
Three More Rare Disease Focused Biotechs Join Queue of Biotech Restructurings
Read More
April 27, 2022
Solid Biosciences Reduces Workforce, Focuses on Advancing DMD Pipeline
Read More
April 18, 2022
Imara Cuts Workforce by 83 Percent, Joining Growing List of Companies Trying to Stay Afloat
Read More
April 14, 2022
Magenta Joins Growing List of Biotechs Reducing Workforce to Extend Cash Runway
Read More
April 5, 2022
Gene Therapy Focused Bluebird Bio Restructures to Extend Cash Runway
Read More
March 22, 2022
Voyager Names Biogen Veteran as New CEO
Read More
March 15, 2022
Rare Disease Focused Biotechs Ovid and Passage Bio Restructure, Conserve Runway
Read More
March 11, 2022
Orphazyme Begins In-Court Restructuring, Reducing Half of Current Workforce
Read More
March 7, 2022
ProQR Appoints John Maraganore as Strategic Advisor to the Supervisory Board
Read More
Load More
X